Tag "osteoporosis"

Back to homepage

Demand for user-friendly and versatile bone growth stimulators has surged

Osteoporosis and osteoarthritis are among the common disabling joint disorders that are affecting millions of elderly people across the world. Some of the most common sites of osteoporotic fractures are


Romosozumab: Bone-forming agent promising for osteoporosis patients

Romosozumab, A new bone-forming agent currently under study by Amgen Inc. and Belgium’s UCB, has shown promise in research into osteoporosis in postmenopausal women with low bone mineral density (BMD).